This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The Deal: CareFusion Slips on GE Vital Signs Purchase

NEW YORK (TheStreet) -- Healthcare product manufacturer CareFusion  (CFN) said Monday, Nov. 18, it would acquire the Vital Signs division of General Electric's  (GE) health division in a deal valued at about $500 million.

Vital Signs makes single-patient-use consumables for respiratory care and anesthesiology as well as products for temperature management and patient monitoring consumables. San Diego-based CareFusion said the unit will expand its disposables business by adding to its global reach and to its product portfolio.

CareFusion shares were dropping 1% to $38.80 in mid-day trading while General Electric was adding 0.9% to $27.45.

About one-third of CareFusion's $250 million in annual sales comes from outside of the United States. The vital signs unit is based in Totowa, N.J., and employs more than 1,000 worldwide including at a manufacturing center in Shenzhen, China.

"The acquisition of vital signs is well-aligned to our long-term growth strategy, helping us create scale in our procedural solutions call points and increase our presence outside of the United States," CareFusion chairman and CEO Kieran T. Gallahue said in a statement. "Together, CareFusion and Vital Signs have the R&D, manufacturing and go-to-market resources to drive innovation, invest for growth and better support customers in major geographic markets."

CareFusion estimates that the annual global market for respiratory and anesthesia consumables is more than $3 billion. The company said it expects to extract upwards of $15 million in annual synergies from the deal by its fiscal 2017.

The deal is CareFusion's eighth acquisition since 2010. The company acquired Rowa Automatisierungssysteme GmbH for $150 million in 2011 and spent $225 million for Medegen a year prior, while also selling its international surgical products distribution business to Medline Industries for $130 million.

Fairfield, Conn.-based GE said that the sale would allow it to focus on its medical device business. "We believe CareFusion is equipped to unlock the growth potential of Vital Signs with a solid focus and strategy around medical consumables," said GE healthcare division president Tom Gentile. --By Lou Whiteman in Atlanta

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,979.13 +59.54 0.35%
S&P 500 1,986.51 +4.91 0.25%
NASDAQ 4,526.4820 -1.0320 -0.02%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs